MetaVia Inc. (MTVA): Operating Cash Flow
-$15.70M
Year ended 2025-12-31
-$15.84M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$15.70M | n/m | 2026-03-26, From 2025-01-01 |
| 2024-12-31 | -$24.71M | n/m | 2026-03-26, From 2024-01-01 |
| 2023-12-31 | -$10.80M | n/m | 2025-03-20, From 2023-01-01 |
| 2022-12-31 | -$11.71M | n/m | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | -$15.13M | n/m | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | -$10.76M | n/m | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | -$7.04M | n/m | 2021-04-15, From 2019-01-01 |
| 2018-12-31 | -$14.45M | n/c | 2020-03-30, From 2018-01-01 |
| 2017-12-31 | -$26.90M | n/m | 2019-03-18, From 2017-01-01 |
| 2016-12-31 | -$11.04M | n/m | 2019-03-18, From 2016-01-01 |
| 2015-12-31 | -$5.43M | n/m | 2018-03-20, From 2015-01-01 |
| 2014-12-31 | -$195.0K | n/a | 2017-03-21, From 2014-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| MetaVia Inc. (MTVA) | 2025-12-31 | -$15.70M | n/m |
| Mira Pharmaceuticals, Inc. (MIRA) | 2025-12-31 | -$4.66M | n/m |
| Decoy Therapeutics Inc. (DCOY) | 2025-12-31 | -$4.83M | n/m |
| Lantern Pharma Inc. (LTRN) | 2025-12-31 | -$15.68M | n/m |
| NewcelX Ltd. (NCEL) | 2025-12-31 | -$2.77M | n/m |
| Curanex Pharmaceuticals Inc (CURX) | 2025-12-31 | -$10.48M | n/m |
| Revelation Biosciences, Inc. (REVB) | 2025-12-31 | -$8.27M | n/m |
| Traws Pharma, Inc. (TRAW) | 2025-12-31 | -$18.18M | n/m |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | 2025-12-31 | -$9.48M | n/m |
Compare MTVA, MIRA, DCOY, LTRN side by side · Screen every company in Pharmaceutical Preparations ↗